Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing iomeprol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iomeprol (substance) |
Inferred relationship |
Some |
1 |
iomeprol 150 mg (I)/ml injektionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 200 mg (I)/ml injektionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 250 mg (I)/ml injektionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 300 mg (I)/ml injektionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 350 mg (I)/ml injektionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 400 mg (I)/ml injektionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 250 mg (I)/ml injektionsvæske, opløsning, flaske a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 250 mg (I)/ml injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 300 mg (I)/ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 300 mg (I)/ml injektionsvæske, opløsning, hætteglas a 75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 300 mg (I)/ml injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 300 mg (I)/ml injektionsvæske, opløsning, hætteglas a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 350 mg (I)/ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 350 mg (I)/ml injektionsvæske, opløsning, hætteglas a 75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 350 mg (I)/ml injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 350 mg (I)/ml injektionsvæske, opløsning, hætteglas a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 350 mg (I)/ml injektionsvæske, opløsning, hætteglas a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 400 mg (I)/ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 400 mg (I)/ml injektionsvæske, opløsning, hætteglas a 75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 400 mg (I)/ml injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 400 mg (I)/ml injektionsvæske, opløsning, hætteglas a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 400 mg (I)/ml injektionsvæske, opløsning, hætteglas a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 150 mg (I)/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 250 mg (I)/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 350 mg (I)/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 300 mg (I)/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
iomeprol 400 mg (I)/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iomeprol (substance) |
Inferred relationship |
Some |
|
Product containing only iomeprol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iomeprol (substance) |
Inferred relationship |
Some |
1 |
Iodine (as iomeprol) 350 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iomeprol (substance) |
Inferred relationship |
Some |
1 |
Iodine (as iomeprol) 400 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iomeprol (substance) |
Inferred relationship |
Some |
1 |
Iodine (as iomeprol) 300 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iomeprol (substance) |
Inferred relationship |
Some |
1 |
Iodine (as iomeprol) 250 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iomeprol (substance) |
Inferred relationship |
Some |
1 |
Iomeprol-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iomeprol (substance) |
Inferred relationship |
Some |
1 |
Product containing only iomeprol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iomeprol (substance) |
Inferred relationship |
Some |
1 |